Treatment of pulmonary arterial hypertension in congenital heart disease in Singapore versus the Netherlands: age exceeds ethnicity in influencing clinical outcome

BACKGROUND: Advanced treatment of pulmonary arterial hypertension (PAH) in congenital heart disease (CHD) is increasingly applied worldwide following the—mainly Western world based—international PAH-CHD guidelines. However, studies comparing clinical presentation and outcome after the initiation of...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neth Heart J
Auteurs principaux: van Riel, A. C. M. J., Schuuring, M. J., van Hessen, I. D., van Dijk, A. P. J., Hoendermis, E. S., Yip, J. W., Mulder, B. J. M., Bouma, B. J.
Format: Artigo
Langue:Inglês
Publié: Bohn Stafleu van Loghum 2016
Sujets:
Original Article - ICIN
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4887299/
https://ncbi.nlm.nih.gov/pubmed/26984567
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12471-016-0820-z
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires